Access cutting-edge intraventricular hemorrhage of prematurity treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Newark location
Preparing your pre-screening questions…
Access intraventricular hemorrhage of prematurity specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related intraventricular hemorrhage of prematurity treatment provided free
Check if you qualify for this intraventricular hemorrhage of prematurity clinical trial in Newark, NJ
No-Cost Study Care
Local to Newark
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers\' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.
Sponsor: Rutgers, The State University of New Jersey
Yes, this clinical trial (NCT06797219) has an active research site in Newark, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for intraventricular hemorrhage of prematurity treatment options in Newark, NJ, this clinical trial (NCT06797219) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intraventricular hemorrhage of prematurity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all intraventricular hemorrhage of prematurity clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Newark — not just this study.
Browse Rheumatoid Arthritis Trials in Newark →